Cargando…

Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination

Detalles Bibliográficos
Autores principales: Abo-helo, Nizar, Muhammad, Emad, Ghaben-amara, Sondus, Panasoff, Josef, Cohen, Shai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325552/
https://www.ncbi.nlm.nih.gov/pubmed/34343675
http://dx.doi.org/10.1016/j.anai.2021.07.021
_version_ 1783731581918117888
author Abo-helo, Nizar
Muhammad, Emad
Ghaben-amara, Sondus
Panasoff, Josef
Cohen, Shai
author_facet Abo-helo, Nizar
Muhammad, Emad
Ghaben-amara, Sondus
Panasoff, Josef
Cohen, Shai
author_sort Abo-helo, Nizar
collection PubMed
description
format Online
Article
Text
id pubmed-8325552
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83255522021-08-02 Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination Abo-helo, Nizar Muhammad, Emad Ghaben-amara, Sondus Panasoff, Josef Cohen, Shai Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021-10 2021-07-31 /pmc/articles/PMC8325552/ /pubmed/34343675 http://dx.doi.org/10.1016/j.anai.2021.07.021 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Abo-helo, Nizar
Muhammad, Emad
Ghaben-amara, Sondus
Panasoff, Josef
Cohen, Shai
Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title_full Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title_fullStr Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title_full_unstemmed Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title_short Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
title_sort specific antibody response of patients with common variable immunodeficiency to bnt162b2 coronavirus disease 2019 vaccination
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325552/
https://www.ncbi.nlm.nih.gov/pubmed/34343675
http://dx.doi.org/10.1016/j.anai.2021.07.021
work_keys_str_mv AT abohelonizar specificantibodyresponseofpatientswithcommonvariableimmunodeficiencytobnt162b2coronavirusdisease2019vaccination
AT muhammademad specificantibodyresponseofpatientswithcommonvariableimmunodeficiencytobnt162b2coronavirusdisease2019vaccination
AT ghabenamarasondus specificantibodyresponseofpatientswithcommonvariableimmunodeficiencytobnt162b2coronavirusdisease2019vaccination
AT panasoffjosef specificantibodyresponseofpatientswithcommonvariableimmunodeficiencytobnt162b2coronavirusdisease2019vaccination
AT cohenshai specificantibodyresponseofpatientswithcommonvariableimmunodeficiencytobnt162b2coronavirusdisease2019vaccination